Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States - PubMed (original) (raw)
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States
Lola Rahib et al. Cancer Res. 2014.
Erratum in
- Cancer Res. 2014 Jul 15;74(14):4006
Abstract
Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the average annual percentage changes in incidence and death rates. Breast, prostate, and lung cancers will remain the top cancer diagnoses throughout this time, but thyroid cancer will replace colorectal cancer as the fourth leading cancer diagnosis by 2030, and melanoma and uterine cancer will become the fifth and sixth most common cancers, respectively. Lung cancer is projected to remain the top cancer killer throughout this time period. However, pancreas and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer-related death by 2030, respectively. Advances in screening, prevention, and treatment can change cancer incidence and/or death rates, but it will require a concerted effort by the research and healthcare communities now to effect a substantial change for the future.
©2014 American Association for Cancer Research.
Similar articles
- [Report of Cancer Incidence and Mortality in China, 2014].
Chen WQ, Li H, Sun KX, Zheng RS, Zhang SW, Zeng HM, Zou XN, Gu XY, He J. Chen WQ, et al. Zhonghua Zhong Liu Za Zhi. 2018 Jan 23;40(1):5-13. doi: 10.3760/cma.j.issn.0253-3766.2018.01.002. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29365411 Chinese. - [Comparison of the latest cancer statistics, cancer epidemic trends and determinants between China and the United States].
Ji YT, Liu SW, Zhang YM, Duan HY, Liu XM, Feng ZW, Li JJ, Lyu ZY, Huang YB. Ji YT, et al. Zhonghua Zhong Liu Za Zhi. 2024 Jul 23;46(7):646-656. doi: 10.3760/cma.j.cn112152-20240208-00068. Zhonghua Zhong Liu Za Zhi. 2024. PMID: 38764329 Chinese. - Cancers with increasing incidence trends in the United States: 1999 through 2008.
Simard EP, Ward EM, Siegel R, Jemal A. Simard EP, et al. CA Cancer J Clin. 2012 Mar-Apr;62(2):118-28. doi: 10.3322/caac.20141. Epub 2012 Jan 4. CA Cancer J Clin. 2012. PMID: 22281605 Review. - Burden of cancer and changing cancer spectrum among older adults in China: Trends and projections to 2030.
Shi Z, Lin J, Wu Y, Fu S, Wan Y, Fang Y. Shi Z, et al. Cancer Epidemiol. 2022 Feb;76:102068. doi: 10.1016/j.canep.2021.102068. Epub 2021 Dec 2. Cancer Epidemiol. 2022. PMID: 34864577 - Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.
Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK. Weir HK, et al. J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
Cited by
- New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count.
Del Campo-Pedrosa R, Martín-Carnicero A, González-Marcos A, Martínez A. Del Campo-Pedrosa R, et al. Front Oncol. 2024 Oct 7;14:1411096. doi: 10.3389/fonc.2024.1411096. eCollection 2024. Front Oncol. 2024. PMID: 39435278 Free PMC article. - Pathophysiological role of microRNA-29 in pancreatic cancer stroma.
Kwon JJ, Nabinger SC, Vega Z, Sahu SS, Alluri RK, Abdul-Sater Z, Yu Z, Gore J, Nalepa G, Saxena R, Korc M, Kota J. Kwon JJ, et al. Sci Rep. 2015 Jun 22;5:11450. doi: 10.1038/srep11450. Sci Rep. 2015. PMID: 26095125 Free PMC article. - A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancer.
Sohal D, Krishnamurthi S, Tohme R, Gu X, Lindner D, Landowski TH, Pink J, Radivoyevitch T, Fada S, Lee Z, Shepard D, Khorana A, Saunthararajah Y. Sohal D, et al. Am J Cancer Res. 2020 Sep 1;10(9):3047-3060. eCollection 2020. Am J Cancer Res. 2020. PMID: 33042633 Free PMC article. - Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxel.
Pegna GJ, Lee MJ, Peer CJ, Ahmad MI, Venzon DJ, Yu Y, Yuno A, Steinberg SM, Cao L, Figg WD, Donahue RN, Hassan R, Pastan I, Trepel JB, Alewine C. Pegna GJ, et al. Cancer Med. 2023 Feb;12(4):4236-4249. doi: 10.1002/cam4.5290. Epub 2022 Oct 8. Cancer Med. 2023. PMID: 36208017 Free PMC article. - Obesity Is Associated with Distal Migration of Pancreatic Adenocarcinoma to Body and Tail: A Multi-Center Study.
Sbeit W, Gershovitz G, Shahin A, Shhadeh S, Salman M, Basheer M, Khoury T. Sbeit W, et al. Cancers (Basel). 2024 Jan 14;16(2):359. doi: 10.3390/cancers16020359. Cancers (Basel). 2024. PMID: 38254848 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical